There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Watanabe, M., et al.: Bioorg. Med. Chem., 5, 437 (1997); Lee, E., et al.: Clin. Pharmacol. Ther., 78, 330 (2005); Ferdinand, K.C., et al.: Am. J. Cardiol., 97, 229 (2006)"
"Methyl 4-(4-Fluorophenyl)-6-isopropyl-2-[N-methyl-N-(methyl-d3-sulfonyl)amino]pyrimidine-5-carboxylate is an intermediate in the synthesis of Rosuvastatin-d3 Sodium Salt, a labeled analogue of Rosuvastatin (R700500), a selective, competitive HMG-CoA reductase inhibitor. Antilipemic."
Hazard Compound
Refer MSDS for complete information.
Overview
"Methyl 4-(4-Fluorophenyl)-6-isopropyl-2-[N-methyl-N-(methyl-d3-sulfonyl)amino]pyrimidine-5-carboxylate is an intermediate in the synthesis of Rosuvastatin-d3 Sodium Salt, a labeled analogue of Rosuvastatin (R700500), a selective, competitive HMG-CoA reductase inhibitor. Antilipemic."
![Methyl 4-(4-Fluorophenyl)-6-isopropyl-2-[N-methyl-N-(methyl-d3-sulfonyl)amino]pyrimidine-5-carboxylate](https://structures.clearsynth.com/CS-T-99169.png)
![D-[2-18O]fructose](https://structures.clearsynth.com/CS-OC-00334.JPG)
